These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 39230257)
1. The effect of the modified Atkins diet and anti-seizure medications on lipid marker levels in adults with epilepsy. Muller AL; Diaz-Arias L; Cervenka MC; McDonald TJW Nutr Neurosci; 2024 Sep; ():1-10. PubMed ID: 39230257 [TBL] [Abstract][Full Text] [Related]
2. The effect of anti-seizure medications on lipid values in adults with epilepsy. Muller AL; Diaz-Arias L; Cervenka MC; McDonald TJW Epilepsy Behav; 2023 Jul; 144():109260. PubMed ID: 37244221 [TBL] [Abstract][Full Text] [Related]
3. Predictors of elevations in fasting lipid levels in adults with epilepsy on a modified Atkins diet. McDonald TJW; Diaz-Arias L; Vizthum D; Henry-Barron BJ; Cervenka MC Seizure; 2023 Dec; 113():86-92. PubMed ID: 38006874 [TBL] [Abstract][Full Text] [Related]
4. Six-month effects of modified Atkins diet implementation on indices of cardiovascular disease risk in adults with epilepsy. McDonald TJW; Diaz-Arias L; Vizthum D; Henry-Barron BJ; Schlechter H; Kossoff EH; Cervenka MC Nutr Neurosci; 2022 Jul; 25(7):1548-1557. PubMed ID: 33487129 [TBL] [Abstract][Full Text] [Related]
5. The impact of the modified Atkins diet on lipid profiles in adults with epilepsy. Cervenka MC; Patton K; Eloyan A; Henry B; Kossoff EH Nutr Neurosci; 2016; 19(3):131-7. PubMed ID: 25383724 [TBL] [Abstract][Full Text] [Related]
6. Ketogenic diets for drug-resistant epilepsy. Martin-McGill KJ; Bresnahan R; Levy RG; Cooper PN Cochrane Database Syst Rev; 2020 Jun; 6(6):CD001903. PubMed ID: 32588435 [TBL] [Abstract][Full Text] [Related]
7. Hypocarnitinemia and its effect on seizure control in adult patients with intractable epilepsy on the modified Atkins diet. Chu DY; Ravelli MN; Faltersack KM; Woods AL; Almane D; Li Z; Sampene E; Felton EA Front Nutr; 2023; 10():1304209. PubMed ID: 38249600 [TBL] [Abstract][Full Text] [Related]
8. Factors associated with initiation of the modified Atkins diet in adults with drug-resistant epilepsy. Quiroga-Padilla PJ; Briceño C; Mayor LC Epilepsy Behav; 2022 Apr; 129():108620. PubMed ID: 35220027 [TBL] [Abstract][Full Text] [Related]
9. Effect of the modified Atkins diet in adults with drug-resistant epilepsy: A controlled study. Quiroga-Padilla PJ; Briceño C; Mayor LC Epilepsy Behav; 2022 Nov; 136():108936. PubMed ID: 36215831 [TBL] [Abstract][Full Text] [Related]
10. Safety, Efficacy, and Tolerability of Modified Atkins Diet in Persons With Drug-Resistant Epilepsy: A Randomized Controlled Trial. Manral M; Dwivedi R; Gulati S; Kaur K; Nehra A; Pandey RM; Upadhyay AD; Sapra S; Tripathi M Neurology; 2023 Mar; 100(13):e1376-e1385. PubMed ID: 36599697 [TBL] [Abstract][Full Text] [Related]
11. Improving compliance in adults with epilepsy on a modified Atkins diet: A randomized trial. McDonald TJW; Henry-Barron BJ; Felton EA; Gutierrez EG; Barnett J; Fisher R; Lwin M; Jan A; Vizthum D; Kossoff EH; Cervenka MC Seizure; 2018 Aug; 60():132-138. PubMed ID: 29960852 [TBL] [Abstract][Full Text] [Related]
12. Modified Atkins diet in children with epilepsy with eyelid myoclonia (Jeavons syndrome). Paibool W; Schimpf S; Nordli DR; Phitsanuwong C Epilepsy Behav; 2023 Aug; 145():109347. PubMed ID: 37459720 [TBL] [Abstract][Full Text] [Related]
13. Modified ketogenic diets in adults with refractory epilepsy: Efficacious improvements in seizure frequency, seizure severity, and quality of life. Roehl K; Falco-Walter J; Ouyang B; Balabanov A Epilepsy Behav; 2019 Apr; 93():113-118. PubMed ID: 30867113 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of ketogenic diet therapy in children diagnosed with drug-resistant epilepsy: a single-center experience. Yıldırım GK; Yağcı M; Uygur AÇ; Özen H; Yarar C; Çarman KB Turk J Pediatr; 2022; 64(3):435-445. PubMed ID: 35899556 [TBL] [Abstract][Full Text] [Related]
16. Factors associated with seizure response in adults with epilepsy on a modified Atkins diet. Huerta N; Lu M; Henry-Barron BJ; Cervenka MC; McDonald TJW Seizure; 2024 Oct; 121():147-151. PubMed ID: 39181013 [TBL] [Abstract][Full Text] [Related]
17. Results of retrospective chart review to determine improvement in lipid goal attainment in patients treated by high-volume prescribers of lipid-modifying drugs. Stacy TA; Egger A J Manag Care Pharm; 2006; 12(9):745-51. PubMed ID: 17249907 [TBL] [Abstract][Full Text] [Related]
18. The Number of Antiseizure Medications Taken and not the Lipid Profile was Associated with Seizure Control in Adult Patients with Epilepsy. Leandro-Merhi VA; de Almeida Souza Tedrus GM; de Moraes GGJ; Ravelli MN CNS Neurol Disord Drug Targets; 2024; 23(8):927-930. PubMed ID: 37587820 [TBL] [Abstract][Full Text] [Related]
19. Effect of classic ketogenic diet treatment on lipoprotein subfractions in children and adolescents with refractory epilepsy. Azevedo de Lima P; Baldini Prudêncio M; Murakami DK; Pereira de Brito Sampaio L; Figueiredo Neto AM; Teixeira Damasceno NR Nutrition; 2017 Jan; 33():271-277. PubMed ID: 27712963 [TBL] [Abstract][Full Text] [Related]
20. The psychiatric effects of ketogenic diet therapy on adults with chronic epilepsy. Shegelman A; Carson KA; McDonald TJW; Henry-Barron BJ; Diaz-Arias LA; Cervenka MC Epilepsy Behav; 2021 Apr; 117():107807. PubMed ID: 33610104 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]